Gynecology

Evidence on which to base management of RPL is limited, challenging ob/gyns with patients facing this stressful diagnosis.

When a jury sees a diagnosis of HIE, it is very difficult to show them that no hypoxia occurred in labor, even in the face of normal cord blood gases.

An update on the Zika virus and its impact on your practice. And, a look at whether or not vaginal delivery increases risk of incontinence. Plus: What was the impact of the HPV vaccine on HPV rates?

Can Zika be considered a sexually transmitted infection?

Surgeons at the Cleveland Clinic performed the procedure in hopes of "curing" absolute uterine-factor infertility, but announced on March 9 that the organ had had to be removed.

A look at the impact of prehypertension on the risk of stillbirth. And, the CDC issues guidance on alcohol consumption in women of childbearing years. Plus: Does the type of hysterectomy alter endometrial cancer survival?

Women with BRCA gene mutations face tough decisions but they have options.

It may difficult to arrive at a diagnosis in cases of acute pain.

A self-sampling device being used in Canada is receiving high marks from patients.

Geographic factors predict likelihood of HPV vaccine initiation rates, a study finds.

A January 4th action by the US Food and Drug Administration (FDA) reclassified transvaginal mesh implants for pelvic organ prolapse (POP) as class III (or high-risk) medical devices requiring premarket approval application (PMA).

The study was designed for tight control of the usual variables.

If proven effective, the vaccine, called VGX-3100, would be the first non-ablative therapy for cervical precancer.

Surgical mesh for pelvic organ prolapse (POP) is a class III or high-risk medical device requiring premarket approval application (PMA) following new action by the Food and Drug Administration (FDA).

Did it occur during surgery, or did a later injury lead to it?

A look at whether or not oral contraceptives help with ovarian cancer survival. Plus: Do false-positive mammogram results serve as a sign of future breast cancer risk?

Forty-six ob/gyns, including members of the Contemporary OB/GYN board, have submitted an open letter to the US Food and Drug Administration regarding its communication on the safety of power morcellation.

Dispatches from the 44th AAGL Global Congress looks at the incidence of occult sarcoma and a look at what patient characteristics may lead to using morcellation during hysterectomy.

The March of Dimes releases their annual report card on the United States and prematurity. Plus: Can anything be done about HPV vaccine rates? Also, a look at the place of ultrasound in breast cancer detection.

In malpractice cases allegations of a failure to follow the chain-of-command policy often are made retrospectively, knowing the bad outcome and claiming that nurses had a responsibility to obtain additional medical care that would have prevented the patient’s injury.

Can you arrive at the correct diagnosis?

Muscle stretch and distention during delivery lead to problems later in life.

The results of a new study on Vitamin D and pregnancy outcome. Plus, Is foam the future of nonsurgical female sterilization? And: Choosing a GnRH dose for ovarian stimulation

A new study examines the risk:benefit of the Essure device. And, does anti-osteoporosis medication in the wake of a fragility fracture reduce the risk of a future fracture? Plus: What role do high maternal blood glucose levels play in her child's future cardiovascular health?

Should NSAIDs be first-line treatment for heavy menstrual bleeding?